Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis

James D. Chalmers (Lead / Corresponding author), Mark L. Metersky, Joseph Feliciano, Carlos Fernandez, Ariel Teper, Andrea Maes, Mariam Hassan, Anjan Chatterjee

    Research output: Contribution to journalArticlepeer-review

    7 Citations (Scopus)
    95 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Benefit-risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis'. Together they form a unique fingerprint.

    Keyphrases

    Pharmacology, Toxicology and Pharmaceutical Science

    Agricultural and Biological Sciences